Ambisome shortage status
1 active shortage notice across 1 country.
Last updated 1 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Ambisome
- Class
- Auto-created by FDA MedWatch — Drug Safety Alerts scraper
Where Ambisome is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| United States | high | 1 | 15 May 2014 | — | FDA MedWatch |
Why Ambisome is in shortage
- regulatory action — e.g. “Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associate…” (United States)
Frequently asked questions
Is Ambisome currently in shortage?
Yes. As of the latest regulator updates, Ambisome has 1 active shortage notice across 1 country (United States). Status is refreshed daily from official regulatory sources.
Why is Ambisome in shortage?
Regulators attribute the current Ambisome shortages to regulatory action. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Ambisome shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Ambisome status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.